Ressource Scientifique
Publication scientifique
01/06/2018
Broad-spectrum Preclinical Antitumor Activity of Eribulin (Halaven®): Combination with Anticancer Agents of Differing Mechanisms
Broad-spectrum Preclinical Antitumor Activity of Eribulin (Halaven®): Combination with Anticancer Agents of Differing Mechanisms
Publication scientifique
17/05/2018
Radiolabeled F(ab’)2-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models
Radiolabeled F(ab')2-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models
Publication scientifique
01/11/2017
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models
Poster
01/10/2017
Synergistic Anticancer Activity of Eribulin Plus Palbociclib in Patient-Derived Xenograft (PDX) Models of ER+/Her2- Human Breast Cancer
Synergistic Anticancer Activity of Eribulin Plus Palbociclib inPatient-Derived Xenograft (PDX) Models of ER+/Her2- Human Breast Cancer
Poster
01/10/2017
Identification by systematic in situ hybridization screen on medaka embryos of new genes as targets for anti-cancer therapy
Identification by systematic in situ hybridization screen on medaka embryos of new genes as targets for anti-cancer therapy
Publication scientifique
01/07/2017
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
Poster
01/04/2017
Single, low dose treatment of lymphoma and renal cancer xenografts with human anti-CD70 antibody-toxin conjugates, results in long term cures
Single, low dose treatment of lymphoma and renal cancer xenografts with human anti-CD70 antibody-toxin conjugates, results in long term cures
